Moleculin Biotech Inc (MBRX)

Trade MBRX now with
9/14/2020 7:39:19 AM Moleculin Biotech To Test Antiviral Activity Of WP1122 In COVID-19 Animal Model
9/9/2020 7:35:40 AM Moleculin Biotech Intends To File IND Using Annamycin For Soft Tissue Sarcomas With Lung Metastases By Year-End
8/12/2020 7:44:19 AM Moleculin Biotech Q2 Net Loss $10.1 Mln Vs. Net Loss Of $1.2 Mln Prior Year
7/21/2020 7:36:08 AM Moleculin Biotech Says New Independent Laboratory Testing Confirms Antiviral Activity Of WP1122 Against Coronavirus
7/15/2020 7:34:24 AM Moleculin Biotech Enters Deal With Sterling Pharma USA LLC For US Production Of WP1122
7/2/2020 7:35:38 AM Moleculin Biotech Announces Update On Clinical Development Plan For Annamycin
6/25/2020 7:34:04 AM Moleculin Announces Preclinical Data Confirms Efficacy Of Annamycin In Lung Metastases
6/4/2020 7:40:35 AM Moleculin Biotech Submits Regulatory Requests To Open Two Addl Clinical Sites For Phase 1/2 Study Of Annamycin In Poland
5/18/2020 7:32:18 AM Moleculin Announces Nasdaq Trading Halt Pending Receipt Of Additional Information
5/11/2020 7:39:59 AM Moleculin Biotech Provides Additional Comments Regarding Trading Halt
5/8/2020 7:32:07 AM Moleculin To Adjourn 2020 Annual Meeting Of Stockholders To June 15, 2020